Click here to return to the NurseWeek.com Homepage   Nurse.com Version 2.0
 
 
Search Site
Select Year:
Search Term:
 
Job Search

Nursing Careers

Career Fairs

Facility & Agency Profiles

Resume Builder

Career Advice

Resources

Salary Wizard

Spotlight On

Career Assessment
Tool


 


Education/CE Marketplace

Unlimited CE

Event Guide

CE Direct

Nursing Schools

Resources

NCLEX Information

 


Weekly Features

Archives

In the News Today

Dear Donna

Nursing Shortage

Up Front

5 Minutes With

NurseWeek/AONE Survey

 
 
Video Health Library

Flu Report

Pollen Report

Nursing Calculators
 





   

 

Breathing Lessons
Changes in asthma management in the last 40 years — and a growing incidence of the disease — make it vital for nurses to refresh their knowledge of the ailment.

 
 
  More NurseWeek Features  
Smoke-Free Zone  
Nurses and patients tackle nicotine addiction
 
Bloodless Survival  
  Surgical techniques to use when transfusion drops out of the equation  

As one of the most common chronic diseases in the United States, asthma affects more than 20 million Americans. Although a number of advances have been made in asthma care, the disease remains a growing public health concern.

A 55-year-old woman who had been admitted to the hospital the previous night was still short of breath when Chris Garvey, MSN, FNP, MPA, entered her room at Seton Medical Center in Daly City, Calif.

Because it was the woman’s first bout of asthma, Garvey explained how certain genetic and environmental factors can trigger asthma, and how patients can become allergic to animal dander, pollen, and other particles in the air.

After explaining how to use the appropriate medications, Garvey suggested they meet with the woman’s primary care physician to devise a long-term asthma management plan.

Garvey is one of many nurses who work with adult asthma patients. As one of the most common chronic diseases in the United States, asthma affects more than 20 million Americans. Although many advances have been made in asthma care, the disease remains a growing public health concern.

According to the national Centers for Disease Control and Prevention, asthma accounts for more than 10 million outpatient clinic visits, and nearly 2 million emergency department visits each year in the United States.

Garvey, who has worked in asthma care for the past 27 years, and is a volunteer with the American Lung Association, also can empathize with the fears and concerns of her patients. Four years ago, she was diagnosed with asthma and chronic bronchitis.

“Patients know I’m speaking from experience,” Garvey said. “I’m a former smoker, so when I tell them smoking exacerbates their asthma symptoms, they take me seriously.”

Two major types of oral and inhaled treatments are used to control asthma symptoms: long-acting medications that prevent and control asthma, and short-acting medications used for relief of asthma symptoms.

Long-acting medications include long-acting bronchodilators and anti-inflammatory drugs such as inhaled corticosteroids that stop or prevent inflammation in the airways. A newer class of asthma medications, called anti-leukotrienes, block leukotriene receptors in the body. This prevents leukotrienes from contributing to inflammation in the airways.

Short-acting inhaled bronchodilators, or inhaled steroids, open the air passages and are generally used as “rescue medications” to stop an asthma attack.

Six years ago, the emergency department at Seton Medical Center was inundated with asthma patients. Realizing that patients weren’t receiving optimal care from their brief ED visits, the hospital instituted a standardized intervention to assist patients in managing their conditions.

“Now, when patients come to the ED, they receive training from a nurse who teaches them to identify triggers, how to use medications, and stresses the importance of following up with their doctor and having an asthma management plan,” Garvey said.

“We teach them asthma can’t be cured but it can be controlled, and through this program we’ve seen our return rate in the ED drop from 56% to 1%.”

Uphill battle

Susan Janson, RN, DNSc, ANP, FAAN, a professor of nursing and medicine at the University of California, San Francisco, and a longtime American Lung Association volunteer, has seen a lot of progress in asthma care, yet she’s also watched the condition become more prevalent.

“The inhaled therapies we use today are more effective than the oral therapies we used years ago,” Janson said. “And I’ve seen significant improvements from teaching patients individualized self-management practices.”

Despite the many advances made in asthma care, more patients are being diagnosed with the condition.

The CDC reports that between 1980 and 1994, the prevalence of asthma increased 75%.

“We’re definitely seeing more adults diagnosed with asthma, including an increase in the number of menopausal women,” Janson said. “We’re not clear if this is due to environmental factors, but women have more severe disease and a higher mortality rate.”

Researchers also note that asthma prevalence varies considerably by race and ethnicity, with Hispanics and African Americans having a much higher incidence rate than other ethnic groups.

In May, the Commonwealth Fund International Working Group on Quality Indicators released a study, How Does the Quality of Care Compare in Five Countries? that found the United States had a higher asthma mortality rate than Australia, Canada, New Zealand, and England among those aged 5 to 39. The study stated the U.S. mortality rate for asthma is higher now than it was 10 years ago, while it has been decreasing in the other countries.

“You wouldn’t think patients would be dying from a treatable disease such as asthma,” Janson said. “Yet there are many disparities in our health care system. Not everyone has access to quality care.”

Janson uses one of San Francisco’s impoverished neighborhoods as an example. “Many patients take three buses to reach our medical center,” Janson said.

Insurance coverage also can be a problem. For example, MediCal doesn’t cover the cost of spacers, a device that is attached to the metered dose inhaler used by asthma patients.